NSE filing, NSE: BALAXI. Summary written from the filing by ALFA Finder's alert engine.
Balaxi Pharmaceuticals Ltd: key numbers
- Share price
- ₹19.15
- Market cap
- ₹105.7 Cr
- Revenue (annual)
- ₹270.2 Cr
- Net profit (annual)
- ₹1.42 Cr
- P/E (TTM)
- 43.6×Sector 45.9×
- Promoter holding
- 65.99%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Balaxi Pharmaceuticals Ltd
All →Balaxi Pharmaceuticals Board Meeting Date
Balaxi Pharmaceuticals will meet on 12 November 2026 to approve unaudited half-year results. The trading window stays closed until 14 November 2026.
Balaxi Pharmaceuticals Other Announcement
Balaxi Pharmaceuticals Limited reported nil activity regarding the re-lodgement of physical share transfer requests for the period ended September 2026.
Balaxi Pharmaceuticals Other Announcement
Balaxi Pharmaceuticals reported nil activity regarding the re-lodgement of physical share transfer requests for August 2026. This is a routine regulatory compliance filing.
Balaxi Pharmaceuticals Business Update
Balaxi Pharmaceuticals has received WHO-GMP certification for its first pharmaceutical formulation manufacturing facility in Telangana. The facility has commenced manufacturing initially approved products for international markets.
Balaxi Pharmaceuticals Management Change
Balaxi Pharmaceuticals Limited shareholders approved the re-appointment of Ms. Akshita Ostwal as an Independent Director for a second five-year term starting September 5, 2026.
Balaxi Pharmaceuticals Investor Presentation: Key Takeaways
Balaxi reported 14.1% YoY revenue growth in Q1 FY27, driven by market diversification and its first proprietary manufacturing facility. Strategy emphasizes backward integration in Latin America and Africa.
Other annual general meeting announcements
All →Raymond Annual General Meeting
Raymond seeks shareholder approval via postal ballot to rename itself Raymond Aerospace, Defence & Engineering Limited. E-voting runs November 1 to 30, 2026.
Shriram Finance Annual General Meeting
Shriram Finance sent a postal ballot notice seeking approval to issue up to Rs.35,000 Crore of private placement debentures. Voting runs 31 October to 29 November 2026.
- Value
- ₹35,000 Cr
- Execution
- One year from the date of passing of the resolution
Milestone Furniture Annual General Meeting
Milestone Furniture issued notice of its 12th AGM on November 21, 2026. Agenda covers accounts, auditors, directors, an ESOP scheme and a debt-conversion share issue.
Chemplast Sanmar Annual General Meeting
Chemplast Sanmar has issued a Notice of Postal Ballot seeking shareholder approval to appoint Mr Prashanth Vasu as Non-Executive, Non-Independent Director. E-voting runs from October 31 to November 29, 2026.
Surani Steel Tubes Annual General Meeting
Surani Steel Tubes' scrutinizer report confirms all three EGM resolutions passed: authorised capital increase, name change and a 98 lakh preferential warrant issue. Each resolution received 100% in-favour votes.
Nova Iron & Steel Annual General Meeting
Nova Iron & Steel held its 34th AGM on October 30, 2026 and filed the proceedings. Business covered FY2026 accounts, director appointments, cost auditor remuneration and a Memorandum of Association alteration.